gadolinium dtpa has been researched along with methotrexate in 10 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (methotrexate) | Trials (methotrexate) | Recent Studies (post-2010) (methotrexate) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 41,593 | 5,666 | 11,969 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | methotrexate (IC50) |
|---|---|---|---|
| Thymidylate synthase | Escherichia coli | 1.8 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 0.211 | |
| Toll-like receptor 4 | Homo sapiens (human) | 1.04 | |
| Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.08 | |
| Dihydrofolate reductase | Homo sapiens (human) | 0.0522 | |
| Dihydrofolate reductase | Mus musculus (house mouse) | 0.0331 | |
| Dihydrofolate reductase | Bos taurus (cattle) | 0.0348 | |
| Dihydrofolate reductase | Gallus gallus (chicken) | 0.0545 | |
| Dihydrofolate reductase | Enterococcus faecium | 0.0014 | |
| Dihydrofolate reductase | Lacticaseibacillus casei | 0.0138 | |
| Thymidylate synthase | Homo sapiens (human) | 0.343 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0147 | |
| Thymidylate synthase | Escherichia coli K-12 | 0.0181 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.1529 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.084 | |
| Folate receptor beta | Homo sapiens (human) | 0.1585 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0011 | |
| Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | 0.0012 | |
| Folate receptor alpha | Homo sapiens (human) | 0.2263 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.0717 | |
| Histidine decarboxylase | Rattus norvegicus (Norway rat) | 0.0014 | |
| Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.01 | |
| Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.01 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
| Reduced folate transporter | Homo sapiens (human) | 0.012 | |
| Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | 0.0174 | |
| Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | 3.2 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0547 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.11 | |
| Dihydrofolate reductase | Bacillus anthracis | 0.0136 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0047 | |
| Proton-coupled folate transporter | Homo sapiens (human) | 0.1207 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
| Fairclough, DL; Fletcher, BD; Hanna, SL; Le, AH; Meyer, WH; Parham, DM | 1 |
| Matsuura, K; Miyazaki, K; Mizutani, H; Okamura, H; Takahashi, M; Torashima, M; Yamashita, Y | 1 |
| al Kawi, MZ; Bohlega, S; Clink, HM; Coates, R; Ernst, P; McLean, DR; Omer, S | 1 |
| Lee, CH; Lee, J; Lee, SK; Song, JH; Suh, JS; Yoon, M | 1 |
| Barentsz, JO; Berger-Hartog, O; Hulsbergen-van der Kaa, C; Kondacki, H; Oosterhof, GO; Ruijs, SH; VanderLaak, JA; Witjes, JA | 1 |
| Eberle, M; Jacobowitz, G; Krinsky, G; Mitnick, H; Riles, T; Rockman, C; Rosenzweig, B; Willis, D | 1 |
| Fukuchi, Y; Gunji, Y; Iwakami, N; Kajiyama, Y; Miura, K; Morio, Y; Ohwada, A; Sato, K; Suzuki, T; Takahashi, K; Yamamoto, A; Yoshioka, M | 1 |
| Eschmann, M; Fritz, J; Horger, M | 1 |
| Claussen, CD; Fierlbeck, G; Henes, J; Horger, M; Kötter, I; Schanz, S; Ulmer, A | 1 |
2 trial(s) available for gadolinium dtpa and methotrexate
| Article | Year |
|---|---|
Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Contrast Media; Evaluation Studies as Topic; Female; Gadolinium DTPA; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Organometallic Compounds; Pentetic Acid; Remission Induction; Remission, Spontaneous; Wrist | 1997 |
Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Contrast Media; Doxorubicin; Female; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Sensitivity and Specificity; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 1998 |
8 other study(ies) available for gadolinium dtpa and methotrexate
| Article | Year |
|---|---|
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Doxorubicin; Female; Gadolinium; Gadolinium DTPA; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methotrexate; Necrosis; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Preoperative Care | 1992 |
Contrast-enhanced dynamic MR imaging of postmolar gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contrast Media; Dactinomycin; Female; Gadolinium DTPA; Humans; Hydatidiform Mole, Invasive; Magnetic Resonance Imaging; Methotrexate; Myometrium; Organometallic Compounds; Pentetic Acid; Peptide Fragments; Pregnancy; Uterine Neoplasms | 1995 |
Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes.
Topics: Adolescent; Antineoplastic Agents; Contrast Media; Cytarabine; Drug Combinations; Female; Gadolinium DTPA; Humans; Injections, Spinal; Magnetic Resonance Imaging; Meglumine; Methotrexate; Organometallic Compounds; Paraplegia; Pentetic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord Diseases | 1994 |
Periaortitis: gadolinium-enhanced magnetic resonance imaging and response to therapy in four patients.
Topics: Aged; Anti-Inflammatory Agents; Arteriosclerosis; Azathioprine; Contrast Media; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Methotrexate; Middle Aged; Prednisone; Retroperitoneal Fibrosis; Rheumatic Diseases; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Clinical evaluation of meningeal carcinomatosis associated with primary lung cancer].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Small Cell; Gadolinium DTPA; Humans; Infusion Pumps; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Retrospective Studies | 2005 |
[Current imaging in Takayasu arteritis].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Child; Contrast Media; Cyclophosphamide; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Takayasu Arteritis; Tomography, Spiral Computed | 2005 |
Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach.
Topics: Adult; Contrast Media; Dermatologic Agents; Female; Gadolinium DTPA; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisolone; Prospective Studies; Scleroderma, Localized; Statistics, Nonparametric; Treatment Outcome | 2013 |